AI is only as credible as the content behind it
Powering AI development with verified research
Artificial intelligence is fundamentally transforming pharmaceutical development, accelerating drug discovery timelines, optimizing clinical trial design and unlocking insights that were previously impossible to achieve. But as AI increasingly drives high stakes decisions that impact patient safety, regulatory approval and commercial success, one critical question demands attention: can you trust the outputs your AI generates?
AI Challenges for Pharma
The effectiveness of any AI system is directly impacted by the quality of its underlying data. Without reliable, verified information, even the most sophisticated AI models can produce flawed results that lead to costly development delays, missed breakthrough opportunities, regulatory compliance risks and compromised data integrity.
In the pharmaceutical industry, where precision, transparency, and credibility aren’t just best practices but essential requirements, the stakes couldn’t be higher. Success depends on ensuring your AI is built on a foundation of trustworthy, scientifically rigorous content that meets both business objectives and stringent regulatory standards.
This comprehensive whitepaper explores the critical foundations necessary for unlocking AI’s full potential in drug development, providing actionable insights to help you build more reliable, compliant, and effective AI systems.
Real-World Success: A Top 10 Pharma Company’s AI Transformation
A leading global pharmaceutical company recently entered into a groundbreaking AI licensing agreement with Taylor & Francis, recognizing the need to seamlessly integrate artificial intelligence into their research workflows while maintaining rigorous compliance standards and ensuring access to high quality, credible, scientific content. This strategic partnership was designed to address a fundamental challenge: how to harness AI’s transformative power without compromising the accuracy, credibility, and regulatory integrity that pharmaceutical innovation demands.
This collaboration reflects both organizations’ shared commitment to a common mission: improving patient outcomes worldwide by accelerating the development and delivery of lifesaving medicines to those who need them most.
Discover the full story and learn how this partnership is reshaping pharmaceutical AI implementation.
How Taylor & Francis Can Support Your AI Initiatives
By integrating Taylor & Francis’s trusted, verified content into your AI models and research workflows, your teams gain the ability to:
Enhance accuracy – Build AI systems on verified, high-quality data that reduces errors and improves predictive reliability
Ensure transparency – Maintain clear provenance and traceability of information sources, critical for regulatory scrutiny and internal validation
Meet regulatory standards – Align with evolving compliance requirements by leveraging content that meets rigorous scientific and ethical standards
Accelerate innovation – Empower researchers to move faster with confidence, knowing their AI-driven insights are grounded in credible research
Taylor & Francis provides the credible, verified research foundation your organization needs to innovate faster, smarter and with greater confidence in an increasingly AI driven landscape.
Request a call with Taylor & Francis
Let’s work together to transform the future of medicine and unock the full potential of AI in pharmaceutical development.
To find out more about how our AI Licensing can support your business needs, please complete the form below and one of our team will be in touch.